Forum Replies Created
Viewing 0 reply threads
- Replies
-
-
- December 19, 2020 at 8:45 pm
Thank you! I also found this: https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.10016Says people who relapsed after targeted adjuvant have similar response rates to immunotherapy as first line in stage 4.
-
Viewing 0 reply threads